Advertisement

Topics

Blood test after taking palbociclib could predict response in advanced breast cancer

11:09 EDT 17 Apr 2018 | Pharmaceutical Journal

Research has shown that testing for PIK3CA levels after taking palbociclib could help predict a progression-free survival, making it the first known biomarker for this therapy.

Original Article: Blood test after taking palbociclib could predict response in advanced breast cancer

NEXT ARTICLE

More From BioPortfolio on "Blood test after taking palbociclib could predict response in advanced breast cancer"

Advertisement
Quick Search
Advertisement
Advertisement